Pharnext SCA
OTC:PNEXF

Watchlist Manager
Pharnext SCA Logo
Pharnext SCA
OTC:PNEXF
Watchlist
Price: 999 999.9999 USD Market Closed
Market Cap: 6T USD

EV/OCF
Enterprise Value to OCF

-215 281.3
Current
-229 044.9
Median
5.5
Industry
Higher than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-215 281.3
=
Enterprise Value
6T USD
/
Operating Cash Flow
-23.9m EUR
 
FR
Pharnext SCA
OTC:PNEXF
Average EV/OCF: 19.7
Negative Multiple: -215 281.3
US
Abbvie Inc
NYSE:ABBV
24.8
US
Amgen Inc
NASDAQ:AMGN
16.3
US
Gilead Sciences Inc
NASDAQ:GILD
14.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -523
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -94.7
AU
CSL Ltd
ASX:CSL
31.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -3 456.7
US
S
Seagen Inc
F:SGT
Negative Multiple: -82.1
NL
argenx SE
XBRU:ARGX
Negative Multiple: -455.1

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A